Brief: ISR Signs Agreement Regarding Investment In Subsidiaries For Development Of Inhaled COVID-19 Vaccine
July 19 (Reuters) - ISR Immune System Regulation Holding AB
ISR.ST :
* SAID ON SUNDAY SIGNED AGREEMENT WITH SINGAPORE RESOURCES
DEVELOPMENT
* AGREEMENT REGARDING INVESTMENT IN SUBSIDIARIES FOR THE
DEVELOPMENT OF INHALED COVID-19 VACCINE
Source text for Eikon: urn:newsml:reuters.com:*:nWkr7FZhnH
Further company coverage: ISR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ISR Immune System Regulation Holding AB (publ)
See all newsBrief: ISR Holding Shares To Be Delisted From Nasdaq First North Growth Market
Brief: Nasdaq Stockholm Hands Over Investigation Of ISR Holding To Disciplinary Committee
Brief: ISR Immune System Regulation Holding Receives Notice Of Objection From Nasdaq
Brief: ISR FY 2022 Oper Loss Widens To SEK 205.1 Mln
Brief: ISR Signs Development Agreements With Catalent